Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 66926 - 66950 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Rosiglitazone	Approved Investigational	ATP5B	506	downregulated	rosiglitazone results in decreased expression of ATP5B mRNA	12q13.3	A23650
Rosiglitazone	Approved Investigational	B3GNT4	79369	upregulated	rosiglitazone results in increased expression of B3GNT4 mRNA	12q24.31	A10216
Rosiglitazone	Approved Investigational	BAD	572	upregulated	rosiglitazone results in increased expression of BAD mRNA	11q13.1	A24100
Rosiglitazone	Approved Investigational	BAG2	9532	upregulated	rosiglitazone results in increased expression of BAG2 mRNA	6p12.1	A10216
Rosiglitazone	Approved Investigational	BAK1	578	upregulated	rosiglitazone results in increased expression of BAK1 mRNA	6p21.31	A24100
Rosiglitazone	Approved Investigational	BAX	581	upregulated	rosiglitazone results in increased expression of BAX mRNA	19q13.33	A24100 A24103
Rosiglitazone	Approved Investigational	BCHE	590	downregulated	rosiglitazone results in decreased expression of BCHE mRNA	3q26.1	A22609
Rosiglitazone	Approved Investigational	BCL2	596	downregulated	rosiglitazone results in decreased expression of BCL2 mRNA	18q21.33	A24103 A24104
Rosiglitazone	Approved Investigational	BCL2L1	598	upregulated	rosiglitazone results in increased expression of BCL2L1 mRNA	20q11.21	A24100
Rosiglitazone	Approved Investigational	BIRC5	332	downregulated	rosiglitazone results in decreased expression of BIRC5 mRNA	17q25.3	A24105 A24106
Rosiglitazone	Approved Investigational	BMI1	648	downregulated	rosiglitazone results in decreased expression of BMI1 mRNA	10p12.2	A24104
Rosiglitazone	Approved Investigational	BRSK1	84446	downregulated	rosiglitazone results in decreased expression of BRSK1 mRNA	19q13.42	A22609
Rosiglitazone	Approved Investigational	BTBD16	118663	downregulated	rosiglitazone results in decreased expression of BTBD16 mRNA	10q26.13	A22609
Rosiglitazone	Approved Investigational	BTG1	694	downregulated	rosiglitazone results in decreased expression of BTG1 mRNA	12q21.33	A22609
Rosiglitazone	Approved Investigational	C8A	731	downregulated	rosiglitazone results in decreased expression of C8A mRNA	1p32.2	A22609
Rosiglitazone	Approved Investigational	C8B	732	downregulated	rosiglitazone results in decreased expression of C8B mRNA	1p32.2	A22609
Rosiglitazone	Approved Investigational	C8G	733	downregulated	rosiglitazone results in decreased expression of C8G mRNA	9q34.3	A22609
Rosiglitazone	Approved Investigational	CA5A	763	downregulated	rosiglitazone results in decreased expression of CA5A mRNA	16q24.2	A22609
Rosiglitazone	Approved Investigational	CALCRL	10203	downregulated	rosiglitazone results in decreased expression of CALCRL mRNA	2q32.1	A10216
Rosiglitazone	Approved Investigational	CALML4	91860	downregulated	rosiglitazone results in decreased expression of CALML4 mRNA	15q23	A22609
Rosiglitazone	Approved Investigational	CAPN5	726	downregulated	rosiglitazone results in decreased expression of CAPN5 mRNA	11q13.5	A22609
Rosiglitazone	Approved Investigational	CARD14	79092	upregulated	rosiglitazone results in increased expression of CARD14 mRNA	17q25.3	A10216
Rosiglitazone	Approved Investigational	CASP3	836	downregulated	rosiglitazone results in decreased expression of CASP3 mRNA	4q35.1	A24100
Rosiglitazone	Approved Investigational	CASP4	837	downregulated	rosiglitazone results in decreased expression of CASP4 mRNA	11q22.3	A24100
Rosiglitazone	Approved Investigational	CAT	847	upregulated	rosiglitazone results in increased expression of CAT mRNA	11p13	A24107

Displaying entries 66926 - 66950 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability